Tchin Darré, Toukilnan Djiwa, Karell Josiane Ogniadé Ladekpo, Bingo K M'Bortche, Baguilane Douaguibe, Abdoul-Samadou Aboubakari, Didier Koumavi Ekouévi, Bayaki Saka
BACKGROUND: The burden of human immunodeficiency virus (HIV) in cervical cancer remains a major public health challenge in developing countries, like Togo. Precancerous lesions include all cellular abnormalities that have malignant potential that can develop into cancer. The objective of this study was to determine the prevalence and factors associated with precancerous cervical lesions in HIV-infected women in our context. METHODS: A cross-sectional descriptive study was carried out from November 31, 2022, to January 31, 2023, in an HIV care center in Lomé (Non-Governmental Organization Espoir Vie Togo [NGO EVT] Grand-Lomé-Togo)...
2024: Clinical Medicine Insights. Oncology